No abstract available
Keywords:
anti-angiogenic drugs; central nervous system; cytoreduction; glioblastoma spheroids; radionecrosis; residual tumor volume; tumor cell invasion; tumor microenvironment.
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. RA is supported by start-up funding from UCL, LRG was supported by grants of IRBIO (Commissariat à l’Energie Atomique et aux Energies Alternatives, CEA) and Electricité de France (EDF), JP was supported by grant PID2019-104766RB-C21 funded by MCIN/AEI/10.13039/501100011033, Basque Government (IT1751-22 and 2023333035) and University of the Basque Country (COLAB22/07). MM-T was supported by a ‘Maria Zambrano’ research contract (number MAZ/2021/03 UP2021-021) funded by the European Union-Next generation EU and Ramon y Cajal Research Fellow RYC2022-038481-by MCIN/AEI/10.13039/501100011033.